Back to Search Start Over

Kocuria Endophthalmitis: Clinical Spectrum and Long-term Outcomes.

Authors :
Amadeo-Oreggioni GP
Ortiz-Ramirez GY
Baquero-Ospina P
Salcedo-Villanueva G
Fromow-Guerra JJ
Velez-Montoya R
Source :
Ocular immunology and inflammation [Ocul Immunol Inflamm] 2022 Oct-Nov; Vol. 30 (7-8), pp. 1768-1774. Date of Electronic Publication: 2021 Jul 20.
Publication Year :
2022

Abstract

Purpose: To expand the knowledge regarding the clinical presentation of Kocuria endophthalmitis.<br />Methods: We included six cases of Kocuria endophthalmitis between January 2018 and December 2020. From all cases, we collected general demographic data, relevant medical, ophthalmological history, microbiological and antibiotic sensitivity results. All cases had a minimum follow-up of 9 months. All cases were treated with intravitreal moxifloxacin and dexamethasone and pars plana vitrectomy. Undiluted vitreous, corneal, conjunctival, and aqueous samples were cultured and analyzed with the Vitek 2 system.<br />Results: The prevalence of Kocuria endophthalmitis was 6%. (95%CI: 2.26%-12.73%). The mean age at diagnosis was 60.5 ± 15.5 years. All patients had poor visual acuity, severe pain, and severe conjunctival hyperemia at diagnosis. Only one case had a significant improvement in visual acuity at the end of the follow-up.<br />Conclusion: Kocuria spp are an emerging cause of endophthalmitis and should be considered as part of the differential diagnosis.

Subjects

Subjects :
Humans
Middle Aged
Aged

Details

Language :
English
ISSN :
1744-5078
Volume :
30
Issue :
7-8
Database :
MEDLINE
Journal :
Ocular immunology and inflammation
Publication Type :
Academic Journal
Accession number :
34283674
Full Text :
https://doi.org/10.1080/09273948.2021.1951304